BRICS Ablation Devices Market (2022-2033)

Rise in Prevalence of Chronic Illnesses

The region is witnessing a surge in cardiovascular disorders, cancer cases, and chronic pain conditions, all of which demand minimally invasive treatment options. With healthcare systems under pressure to manage long-term disease burdens, ablation devices are being adopted as cost-effective alternatives to open surgery, offering shorter recovery times and reduced hospital stays.

Older patients are more susceptible to atrial fibrillation, liver tumors, and musculoskeletal disorders, conditions where ablation therapies have proven effective. This demographic trend is creating a sustained need for ablation devices, particularly those that can be integrated into outpatient care models to ease the strain on hospitals.

Rising urbanization and lifestyle changes are contributing to higher incidences of chronic illnesses. Sedentary habits, dietary shifts, and increased exposure to environmental risk factors are fueling cardiovascular and oncology cases. As healthcare providers seek to modernize treatment pathways, ablation devices are positioned as a critical solution to address these evolving health challenges.

Insights into Combination Therapy Applications

Healthcare providers are integrating ablation with systemic treatments such as chemotherapy, immunotherapy, and pharmacological interventions to enhance patient outcomes. This approach is effective in oncology, where combining ablation with drug-based therapies reduces recurrence rates and improves survival prospects.

In cardiovascular care, ablation is being paired with medication regimens to manage atrial fibrillation and other rhythm disorders. This dual strategy improves treatment efficacy and reduces the likelihood of hospital readmissions, aligning with regional healthcare priorities focused on efficiency and cost reduction. The integration of ablation into broader therapeutic frameworks reflects a shift toward holistic, patient-centered care models.

Pain management and musculoskeletal treatments are benefiting from combination approaches. By coupling ablation with targeted drug delivery or physiotherapy, clinicians are achieving better long-term outcomes for patients with chronic pain conditions. These innovations highlight how ablation devices are evolving beyond standalone applications, becoming integral to multi-modal treatment strategies that address the complex healthcare needs of the region.

The "BRICS Ablation Devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• BRICS Ablation Devices market size and forecast at regional, and country levels for all market segments covered under the scope
• BRICS Ablation Devices market trends, as well as drivers, restraints, and opportunities
• BRICS Ablation Devices market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the BRICS Ablation Devices market
• Detailed company profiles, including SWOT analysis

The geographical scope of the BRICS Ablation Devices market report is divided into: Russia, Brazil, South Africa, India, China, Egypt, Indonesia, Saudi Arabia, and the UAE. China held the largest share in 2025.

Urban centers across these economies are leading adoption, with hospitals and specialty clinics investing in advanced ablation technologies to address the rising burden of cardiovascular disease and cancer. Private healthcare providers are playing a pivotal role, introducing modern treatment options and driving patient preference for minimally invasive procedures. Local manufacturers are emerging as competitive players, offering cost-effective solutions that appeal to domestic markets, while international companies are strengthening their presence through partnerships and distribution networks. Despite these advancements, disparities in healthcare access remain a challenge, as rural and underserved areas often lack the resources and expertise required for advanced procedures. Regulatory hurdles create delays in product approvals, adding complexity for global entrants. Nonetheless, the region’s ongoing healthcare reforms and rising patient demand ensure that ablation devices will continue to gain traction. The BRICS market is evolving into a critical hub for innovation and expansion, with opportunities concentrated in areas where affordability, accessibility, and advanced technology converge.

• The report includes qualitative and quantitative data in the BRICS Ablation Devices market across technology type, application, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the BRICS Ablation Devices market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the BRICS Ablation Devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the BRICS Ablation Devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 10 cover the BRICS Ablation Devices market segments by technology type, application, end user, and geography across Russia, Brazil, South Africa, India, China, Egypt, Indonesia, Saudi Arabia, and the UAE. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the BRICS Ablation Devices market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

The BRICS Ablation Devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the BRICS Ablation Devices market are:

• In July 2024, Boston Scientific announced that its FARAPULSE Pulsed Field Ablation System received regulatory approval in China for the treatment of atrial fibrillation, marking a milestone in expanding access to advanced ablation technology in one of the largest BRICS healthcare markets.
• In August 2022, Medtronic announced that it had completed the acquisition of Affera, Inc., expanding its cardiac ablation portfolio by adding an integrated cardiac mapping and ablation platform—including advanced pulsed field and radiofrequency technologies—to strengthen its electrophysiology offerings globally, which supports its strategy in markets such as India and China.